Carregant...
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma
INTRODUCTION: Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma and is an aggressive malignancy with heterogeneous outcomes. Diverse methods for DLBCL outcomes assessment ranging from clinical to genomic have been developed with variable predictive and prognostic success....
Guardat en:
| Publicat a: | Expert Rev Hematol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821591/ https://ncbi.nlm.nih.gov/pubmed/31513757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2019.1660159 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|